Case Studies
Evaluation of AlerionTM Microbubble Cell Separation System: T Cell Isolation for Healthier Cells
Poseida Therapeutics, a clinical-stage allogeneic-focused therapeutic developer leveraging proprietary technologies to create life-saving cell therapies, selected the Akadeum platform, consisting of the new AlerionTM Microbubble Cell Separation System, the innovative BioRiseTM consumable, and the Human T Cell Leukopak Isolation Kit, to improve workflows for its cancer and genetic disease solutions. The goal was to improve cell health, cell viability, impurity clearance, T cell recovery, scalability, process consistency, and processing time compared to their optimized magnetic cell separation method.
Enhanced T Cell Banking With Akadeum’s AlerionTM Microbubble Cell Separation System
Akadeum Life Sciences has partnered with a cell therapy AlerionTM Microbubble Cell Separation System beta customer to help their team develop an improved method for T cell banking. The company faces significant challenges in recovery, purity, and processing time with its existing manual methods, and Akadeum’s AlerionTM is well suited to overcome the challenges with its proven superior cell recovery, purity, and scalability.